Therefore, tumor biomarkers have already been used for specific cancer identification, including carcinoembryonic antigen (CEA) for colorectal cancer [24], α-fetoprotein (AFP) for liver cancer [16] and prostate specific antigen (PSA) [52]. This evidence concerns the gene KLK3 and neoplasm.